According to filings with the U.S. Securities and Exchange Commission, DIH Holding US is raising $1,500,000.00 in new funding. About DIH Holding US: DIH Holding US, Inc. operates as a robotics and virtual reality technology…
According to filings with the U.S. Securities and Exchange Commission, Cogent Biosciences is raising $225,000,000.00 in new funding. About Cogent Biosciences: Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined…
According to filings with the U.S. Securities and Exchange Commission, Biofrontera is raising $8,000,000.00 in new funding. About Biofrontera: Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of…
According to filings with the U.S. Securities and Exchange Commission, SeLux Diagnostics is raising up to $45,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Steve Lufkin played a…
According to filings with the U.S. Securities and Exchange Commission, Sea Street Technologies is raising up to $25,094,695.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Harley Stowell played…
According to filings with the U.S. Securities and Exchange Commission, NextPoint Therapeutics is raising up to $42,479,388.00 in new funding. Sources indicate that as part of senior management Secretary and Treasurer, Paul Conrad played a…
According to filings with the U.S. Securities and Exchange Commission, LearnLux is raising up to $7,099,986.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Rebecca Liebman played a key…
According to filings with the U.S. Securities and Exchange Commission, Kytopen is raising up to $8,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Michael Chiu played a key…
According to filings with the U.S. Securities and Exchange Commission, Feon Energy is raising up to $8,074,996.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Wenxiao Huang played a…
According to filings with the U.S. Securities and Exchange Commission, Biomakers is raising up to $7,999,999.00 in new funding. Sources indicate that as part of senior management President, Nicolas Kirchuk played a key role in…